Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis

Long-chain non-coding RNA ASB16-AS1 has been proven to be an oncogene for many cancer types. However, the relationship between ASB16-AS1 and immunity is still under studied. This study aims to explore the expression and prognostic potential of ASB16-AS1, and to visualize the relationship between ASB...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Linyong Wu, Wei Liao, Xiaodong Wang, Yujia Zhao, Jinshu Pang, Yuji Chen, Hong Yang, Yun He
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/2acd64a48a514da09e972e92981218b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2acd64a48a514da09e972e92981218b8
record_format dspace
spelling oai:doaj.org-article:2acd64a48a514da09e972e92981218b82021-11-04T15:51:54ZExpression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis2165-59792165-598710.1080/21655979.2021.1996054https://doaj.org/article/2acd64a48a514da09e972e92981218b82021-10-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.1996054https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Long-chain non-coding RNA ASB16-AS1 has been proven to be an oncogene for many cancer types. However, the relationship between ASB16-AS1 and immunity is still under studied. This study aims to explore the expression and prognostic potential of ASB16-AS1, and to visualize the relationship between ASB16-AS1 expression and immune infiltration in pan-cancer. We clarified ASB16-AS1 expression patterns in pan-cancer and its relationship with prognosis through multi-platform and multi-database sources (TCGA, GEO, GTEx, ArrayExpress, and SRA), and verified the function of ASB16-AS1 in liver hepatocellular carcinoma (LIHC). Then, a variety of immune cell content evaluation methods were used to mutually verify the correlation between ASB16-AS1 and immune infiltration. Finally, the relationships between ASB16-AS1 and some molecular characteristics (immune checkpoints, tumor mutation burden, microsatellite instability, oncogenic signaling pathways) were further explored. In terms of comprehensive analysis, compared with non-tumor tissues, ASB16-AS1 was highly expressed in tumor tissues, and indicated the value of poor prognosis in multiple cancer types. Functional assays, such as CCK8 assay, transwell assay and wound scratch assay, verified that high ASB16-AS1 expression promoted tumor progression in LIHC. ASB16-AS1 was positively correlated with B cells, T cell CD4+ and T cell CD8+ in most cancer types, and negatively correlated with macrophages, dendritic cells and neutrophils in some cancer types, especially in neutrophils. In addition, there were different interaction modes between ASB16-AS1 and molecular features, such as the relationship with oncogenic signaling pathways, showing that the high ASB16-AS1 expression was related to alterations in oncogenic signaling pathways. Our study emphasizes that ASB16-AS1 is a potential pan-cancer prognostic marker, whichs is associated with the immune infiltration in multiple cancer types.Linyong WuWei LiaoXiaodong WangYujia ZhaoJinshu PangYuji ChenHong YangYun HeTaylor & Francis Grouparticlepan-cancerlong-chain non-coding rna asb16-as1prognosisimmune infiltrationmolecular characteristicsBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic pan-cancer
long-chain non-coding rna asb16-as1
prognosis
immune infiltration
molecular characteristics
Biotechnology
TP248.13-248.65
spellingShingle pan-cancer
long-chain non-coding rna asb16-as1
prognosis
immune infiltration
molecular characteristics
Biotechnology
TP248.13-248.65
Linyong Wu
Wei Liao
Xiaodong Wang
Yujia Zhao
Jinshu Pang
Yuji Chen
Hong Yang
Yun He
Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
description Long-chain non-coding RNA ASB16-AS1 has been proven to be an oncogene for many cancer types. However, the relationship between ASB16-AS1 and immunity is still under studied. This study aims to explore the expression and prognostic potential of ASB16-AS1, and to visualize the relationship between ASB16-AS1 expression and immune infiltration in pan-cancer. We clarified ASB16-AS1 expression patterns in pan-cancer and its relationship with prognosis through multi-platform and multi-database sources (TCGA, GEO, GTEx, ArrayExpress, and SRA), and verified the function of ASB16-AS1 in liver hepatocellular carcinoma (LIHC). Then, a variety of immune cell content evaluation methods were used to mutually verify the correlation between ASB16-AS1 and immune infiltration. Finally, the relationships between ASB16-AS1 and some molecular characteristics (immune checkpoints, tumor mutation burden, microsatellite instability, oncogenic signaling pathways) were further explored. In terms of comprehensive analysis, compared with non-tumor tissues, ASB16-AS1 was highly expressed in tumor tissues, and indicated the value of poor prognosis in multiple cancer types. Functional assays, such as CCK8 assay, transwell assay and wound scratch assay, verified that high ASB16-AS1 expression promoted tumor progression in LIHC. ASB16-AS1 was positively correlated with B cells, T cell CD4+ and T cell CD8+ in most cancer types, and negatively correlated with macrophages, dendritic cells and neutrophils in some cancer types, especially in neutrophils. In addition, there were different interaction modes between ASB16-AS1 and molecular features, such as the relationship with oncogenic signaling pathways, showing that the high ASB16-AS1 expression was related to alterations in oncogenic signaling pathways. Our study emphasizes that ASB16-AS1 is a potential pan-cancer prognostic marker, whichs is associated with the immune infiltration in multiple cancer types.
format article
author Linyong Wu
Wei Liao
Xiaodong Wang
Yujia Zhao
Jinshu Pang
Yuji Chen
Hong Yang
Yun He
author_facet Linyong Wu
Wei Liao
Xiaodong Wang
Yujia Zhao
Jinshu Pang
Yuji Chen
Hong Yang
Yun He
author_sort Linyong Wu
title Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
title_short Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
title_full Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
title_fullStr Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
title_full_unstemmed Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis
title_sort expression, prognosis value, and immune infiltration of lncrna asb16-as1 identified by pan-cancer analysis
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/2acd64a48a514da09e972e92981218b8
work_keys_str_mv AT linyongwu expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT weiliao expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT xiaodongwang expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT yujiazhao expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT jinshupang expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT yujichen expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT hongyang expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
AT yunhe expressionprognosisvalueandimmuneinfiltrationoflncrnaasb16as1identifiedbypancanceranalysis
_version_ 1718444705045282816